Preserving brain health after intracerebral haemorrhage
- PMID: 34687620
- DOI: 10.1016/S1474-4422(21)00339-2
Preserving brain health after intracerebral haemorrhage
Conflict of interest statement
JR is supported by the National Institutes of Health (R01NS036695, R01NS093870, R01NS100178, R01NS103924, R01AG067019, U01NS102289, and UO1NS069763), the American Heart Association (812095), and One Mind for Research; and serves as a consultant to Boehringer Ingelheim and Takeda.
Comment in
-
Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial.Lancet Neurol. 2021 Nov;20(11):907-916. doi: 10.1016/S1474-4422(21)00298-2. Lancet Neurol. 2021. PMID: 34687635
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources